Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

4.06
Delayed Data
As of Aug 03
 +0.02 / +0.50%
Today’s Change
3.26
Today|||52-Week Range
6.28
+17.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$977.8M

Company Description

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovery, development and commercialization of drugs in the therapeutic areas such as cardiovascular, central nervous system, inflammatory and metabolic diseases. Its product pipeline includes Lorcaserin, APD334, APD371, temanogrel and nelotanserin. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.

Contact Information

Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego California 92121
P:(858) 453-7200
Investor Relations:
185845372001347

Employees

Shareholders

Individual stakeholders4.43%
Mutual fund holders33.60%
Other institutional24.67%

Top Executives

Jack LiefChairman, President, CEO & CFO
Craig M. AudetSVP-Operations & Head-Global Regulatory Affairs
Dominic P. BehanChief Scientific Officer, Executive Director & EVP
William R. ShanahanChief Medical Officer & Senior Vice President
K. A. Ajit-SimhSenior VP-Quality & Regulatory Compliance